investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Modulators of Prostate Cancer Metastasis
Bruce R Zetter
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Peter B Dervan
Programmable DNA Binding Oligomers for Control of Transcription
Prostate
Martin Brechbiel
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
Prostate
William Figg
Development of Angiogenesis Inhibitors
Prostate
James P Quigley
Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression
Prostate
Pathology
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Prostate
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Prostate
Pathology
Hematology and hematologic malignancies
Towia A Libermann
Role of Axl in docetaxel resistance in prostate cancer
Prostate
Pathology
Serigne Magueye
Ethnic Difference in Prostate Cancer
Prostate
Pathology
Brett Stewart Carver
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Prostate